MoneyWorks4Me

Clarification sought from Sun Pharmaceutical Industries

16 Feb 2017 Evaluate

The Exchange has sought clarification from Sun Pharmaceutical Industries on February 16, 2017, with reference to news appeared in CNBC TV 18 dated February 16, 2017 ‘UK Regulator approves Sun Pharma Generic drug of Tobramycin.’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1801.00
Dr. Reddys Labs. 1209.15
Cipla 1343.00
Lupin 2035.00
Zydus Lifesciences 1160.00
View more..